DRTSW NASDAQ
Alpha Tau Medical Ltd.
1W: +3.6%
1M: +8.0%
3M: +4.6%
YTD: +997.3%
1Y: +1253.3%
3Y: +1339.2%
$4.06
+0.04 (+1.00%)
Weekly Expected Move ±10.0%
$3
$4
$4
$4
$5
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
-$1M
-11.8% ▼
Operating Income
-$42M
-17.3% ▼
Net Income
-$43M
-34.3% ▼
EPS (Diluted)
$-0.53
-17.8% ▼
EBITDA
-$41M
-35.5% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $776K | $979K | $1M | $1M | $1M |
| Gross Profit | -$776K | -$979K | -$1M | -$1M | -$1M |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $11M | $21M | $26M | $27M | $31M |
| SG&A Expenses | $2M | $11M | $9M | $8M | $10M |
| Operating Expenses | $14M | $32M | $35M | $35M | $41M |
| Operating Income | -$14M | -$32M | $36M | -$36M | -$42M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $13M | $2M | $39K | $344K | $419K |
| Income Before Tax | -$27M | -$34M | -$29M | -$32M | -$43M |
| Tax Expense | $7K | $20K | $16K | $6K | $121K |
| Net Income | -$27M | -$34M | -$29M | -$32M | -$43M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-0.67 | $-0.53 | $-0.42 | $-0.45 | $-0.53 |
| EBITDA | -$13M | -$33M | -$28M | -$30M | -$41M |
| Shares Outstanding | 41M | 64M | 69M | 70M | 81M |